The benefit of ACE inhibitors, ARBs, and statins is that they are already used routinely for the treatment of hypertension and hypercholesterolemia, and as such are easily accessible, and have a well-recognized safety profile. This evidence concerns the gene ACE and Hypercholesterolemia.